- Report
- May 2026
- 165 Pages
Global
From €3495EUR$3,950USD£2,995GBP
- Report
- August 2026
- 318 Pages
Global
From €2971EUR$3,358USD£2,546GBP
€3714EUR$4,197USD£3,182GBP
- Report
- September 2025
- 327 Pages
Global
From €3714EUR$4,197USD£3,182GBP
- Report
- January 2026
- 381 Pages
Global
From €3714EUR$4,197USD£3,182GBP
- Report
- May 2026
- 700 Pages
Global
From €4420EUR$4,995USD£3,787GBP
- Report
- May 2026
- 800 Pages
Global
From €4420EUR$4,995USD£3,787GBP
- Report
- May 2026
- 350 Pages
Global
From €3535EUR$3,995USD£3,029GBP
- Report
- March 2026
- 235 Pages
Global
From €4246EUR$4,799USD£3,639GBP
- Report
- January 2026
- 187 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- April 2026
- 148 Pages
Global
From €2654EUR$2,999USD£2,274GBP
€3538EUR$3,999USD£3,032GBP
- Report
- January 2026
- 193 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 365 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- August 2026
- 192 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 193 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 196 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 189 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 193 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 192 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 186 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP

The Cell Therapeutic market is a subset of the biopharmaceutical industry, focusing on the development and commercialization of cell-based therapies. These therapies involve the use of living cells, either from the patient or from a donor, to treat a variety of diseases. Cell therapies can be used to replace or repair damaged cells, to stimulate the body's own immune system to fight disease, or to deliver drugs directly to the site of a disease. Cell therapies are being developed for a wide range of diseases, including cancer, autoimmune diseases, and genetic disorders.
Cell therapies are often complex and expensive to develop, and require specialized manufacturing processes. As a result, the Cell Therapeutic market is highly regulated, with stringent safety and efficacy requirements.
Some companies in the Cell Therapeutic market include Kite Pharma, Juno Therapeutics, and Bluebird Bio. Show Less Read more